| human | Q5 |
| P6178 | Dimensions author ID | 010513411217.30 |
| P6634 | LinkedIn personal profile ID | pierre-henry-gabrielle-64b67919 |
| P496 | ORCID iD | 0000-0002-9688-4845 |
| P3829 | Publons author ID | 1655546 |
| P1053 | ResearcherID | Y-4971-2018 |
| P2038 | ResearchGate profile ID | Pierre_Henry_Gabrielle |
| P1153 | Scopus author ID | 57194323368 |
| P108 | employer | Centre Hospitalier Regional Universitaire De Dijon | Q2945762 |
| P106 | occupation | researcher | Q1650915 |
| Q88229251 | Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients |
| Q91713164 | Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients |
| Q89961763 | Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity |
| Q92481461 | Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter Study |
| Q38747837 | Cholesterol metabolism and glaucoma: Modulation of Muller cell membrane organization by 24S-hydroxycholesterol. |
| Q91729494 | Development of a 1-year risk-prediction nomogram for good functional response with anti-VEGF agents in naive diabetic macular oedema |
| Q99633721 | Full-field optical coherence tomography for the diagnosis of giant cell arteritis |
| Q92887374 | Influence of cardiac hemodynamic variables on retinal vessel density measurement on optical coherence tomography angiography in patients with myocardial infarction |
| Q102070171 | Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry |
| Q92547165 | One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation |
| Q50027867 | POPPER MACULOPATHY: LONG-TERM FOLLOW-UP AND CASE SERIES. |
| Q91834018 | Perioperative risk of bleeding with antithrombotic agents in macular surgery: a national, prospective, multicentre study |
| Q91251110 | Peripapillary Versus Macular Combined Hamartoma of the Retina and Retinal Pigment Epithelium: Imaging Characteristics |
| Q92606665 | Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry |
| Q90198289 | Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results |
| Q64911569 | Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study. |
| Q113696216 | Repeatability and Reproducibility of Retinal Fractal Dimension Measured with Swept-Source Optical Coherence Tomography Angiography in Healthy Eyes: A Proof-of-Concept Study |
| Q92419589 | Retinal Vascular Density as A Novel Biomarker of Acute Renal Injury after Acute Coronary Syndrome |
| Q88581156 | Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema |
| Q100560468 | Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi-the SON study |
| Q92488543 | Subfoveal Choroidal Thickness, Cardiovascular History, and Risk Factors in the Elderly: The Montrachet Study |
| Q91357840 | Subretinal Drusenoid Deposits in the Elderly in a Population-Based Study (the Montrachet Study) |
| Q58130267 | The EYE-MI Pilot Study: A Prospective Acute Coronary Syndrome Cohort Evaluated With Retinal Optical Coherence Tomography Angiography |
| Q88214982 | [Spasm of iris dilator muscle or tadpole-shaped pupil] |
Search more.